ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD
April 29, 2019According to the National Institute of Mental Health, MDD affects approximately 16 million adults in the U.S. with approximately 2.5 million adults treated with adjunctive therapy. -
Acadia Pharma Stock Plummets After FDA Head Tells Congress Parkinson’s Drug Under Investigation
April 27, 2018Acadia Pharmaceuticals shares dropped 22 percent yesterday after U.S. Food and Drug Administration (FDA) commissioner Scott Gottlieb told Congress the agency would investigate the company’s Nuplazid.
Pharma Sources Insight January 2025
